CG Life x The Considered: Combining as one AI-native, integrated team. Find out more

Expertise + AI: Purpose-built for your ambitious goals.

About CG Life x The Considered

When biopharma and precision medicine innovators discover, develop, and launch breakthrough therapies for rare, specialty, and hard-to-treat diseases, they go where no one has gone before. It's a remarkable opportunity and challenge that requires the right partner.

For a quarter century, we've been rooted in the discipline and rigor of translating scientific discovery into brand experiences, helping innovators activate the potential of their products and connecting much-needed therapies to patients.

Today, CG Life and The Considered have come together to deliver even greater precision, differentiation, and acceleration. We call it rare intelligence for commercialization—the combined power of an AI-native agency with commercialization expertise.

Rules of the Road

Move with Purpose.

We translate science into meaning, engagement into action, and creativity into real-world impact for our clients and the patients they serve.

Build with Trust.

We assume positive intent, listen before reacting, and help without hesitation. We are willing to tell and accept the last 10% of the truth.

Master your Craft.

In a field that never stops evolving, we embrace innovation to be best in class. We seek every available resource, technology, and mentor to improve our craft.

Sweat the Details.

We bring urgency, discipline, and accountability to everything we do—because the details matter. We show up prepared, stay grounded when under pressure, and follow through until the work is done.

Lead with Heart.

Behind every data point is a human story. We create space for authentic connections, joy in the work, and laughter along the journey. That's when magic happens.

Our Team at a Glance

250+ Employees worldwide24-hr Follow-the-sun operations100% AI-integrated departments25 Year history
CG Life and The Considered have curated an agile, global workforce of talented specialists to address the weak spots in biopharma and precision medicine commercialization.

The Journey Starts Now